Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021 is a research paper published in Influenza and Other Respiratory Viruses (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Immunization and Respiratory Diseases
Grant: U01IP001034
National Center for Immunization and Respiratory Diseases
Grant: U01IP001035
National Center for Immunization and Respiratory Diseases
Grant: U01IP001036
National Center for Immunization and Respiratory Diseases
Grant: U01IP001037
National Center for Immunization and Respiratory Diseases
Grant: U01IP001038
National Center for Immunization and Respiratory Diseases
Grant: U01IP001039
National Institutes of Health
Grant: UL1TR001857
Henry Ford Health System
University of Michigan
Kaiser Permanente
Baylor Scott and White Health
Marshfield Clinic Research Institute
Medical Center, University of Pittsburgh
University of Pittsburgh
Washington Research Institute
FWCI
0.58
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals